D Molecular Therapeutics, Inc.’s FDMT share price has surged by 5.88%, which has investors questioning if this is right time ...

“We discovered topological charge vectors in four dimensions (4D) that govern the real-space topology of 2D quasicrystals and reveal their inherent conservation laws,” the study authors not ...

4D Molecular Therapeutics, Inc., a late-stage biotechnology company, engages in the development of adeno-associated virus vectors from its proprietary synthetic vector discovery platform ...

David Kirn is co-founder and CEO of 4D Molecular Therapeutics (4DMT), a company using directed evolution to invent new adeno-associated virus (AAV) vectors that are tailored to specific target ...